BIKTARVY 50 mg/200 mg/25 mg, film-coated tablet 90 tablets
Active ingredients: Bictegravir, Bictegravir sodium, Emtricitabine, Tenofovir alafenamide fumarate, Tenofovir alafenamide
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BIKTARVY 50 mg/200 mg/25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) PVC polyéthylène polychlortrifluoroéthylène de 30 comprimé(s)
- Marketing authorisation holder
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Nov 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62844771CIP73022843CIP133400930228432Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EMTRICITABINEcomprimé | 200 mg · un comprimé | SA |
| FUMARATE DE TÉNOFOVIR ALAFÉNAMIDEcomprimé | — | SA |
| BICTÉGRAVIRcomprimé | 50 mg · un comprimé | FT |
| TÉNOFOVIR ALAFÉNAMIDEcomprimé | 25 mg · un comprimé | FT |
| BICTÉGRAVIR SODIQUEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.